Four new coumarinolignans, antidesmanin A (=7‐(1,1‐dimethylallyl)‐2,3‐dihydro‐3‐(4‐hydroxy‐3,5‐dimethoxyphenyl)‐10‐methoxy‐2‐methyl‐6H‐1,4,5‐trioxaphenanthren‐6‐one; 1), antidesmanin B (=3,7‐bis(1,1‐dimethylallyl)‐2,3‐dihydro‐2‐(4‐hydroxy‐3‐methoxyphenyl)‐10‐methoxy‐6H‐1,4,5‐trioxaphenanthren‐6‐one; 2), antidesmanin C (=2,7‐bis‐(1,1‐dimethylallyl)‐2,3‐dihydro‐3‐(4‐hydroxy‐3‐methoxyphenyl)‐10‐methoxy‐6H‐1,4,5‐trioxaphenanthren‐6‐one; 3) and antidesmanin D (=2‐(3,4‐dihydroxyphenyl)‐3,7‐bis(1,1‐dimethylallyl)‐2,3‐dihydroxy‐10‐methoxy‐6H‐1,4,5‐trioxaphenanthren‐6‐one or 3‐(3,4‐dihydroxyphenyl)‐2,7‐bis(1,1‐dimethylallyl)‐2,3‐dihydro‐10‐methoxy‐6H‐1,4,5‐trioxaphenanthren‐6‐one; 4) have been isolated from the root of the Formosan Antidesma pentandrum var. barbatum. The structures of these new compounds were elucidated by spectroscopic data. Compounds 1–3 exhibited marginal cytotoxicity against MCF‐7 (breast) and SF‐268 (CNS) cancer cell lines in vitro.